“…At five‐year follow‐up, the use of a Ring+Sling was associated with a smaller left ventricular end‐diastolic diameter (57 mm vs. 61 mm; p = 0.001) and greater ejection fraction (44% vs. 40%; p < 0.001), a lower prevalence of moderate or greater recurrent MR (27% vs. 56%; p = 0.01), and similar survival (77% vs. 71%; p = 0.71), as compared with a Ring only. Previous retrospective studies have reported the mid‐term prevalence of recurrent moderate or greater MR as 3.4–6% after a Ring+Sling, with a cumulative survival of approximately 80% . The present study adds to this published data, and supports the use of a Ring+Sling for both ischemic and non‐ischemic cardiomyopathy, as well as its application through a right thoracotomy approach.…”